Browse by UCL people
Group by: Type | Date
Jump to: Article | Digital scholarly resource
Number of items: 57.
Article
Asad, H;
Collins, IJ;
Goodall, RL;
Crichton, S;
Hill, T;
Doerholt, K;
Foster, C;
... Collaborative HIV Paediatric Study (CHIPS) Steering Committee, t; + view all
(2021)
Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK.
HIV Medicine
10.1111/hiv.13096.
(In press).
|
Bailey, H;
Turkova, A;
Thorne, C;
(2017)
Syphilis, hepatitis C and HIV in Eastern Europe.
Current Opinion in Infectious Diseases
, 30
(1)
pp. 93-100.
10.1097/QCO.0000000000000326.
|
Bamford, A;
Turkova, A;
Lyall, H;
Foster, C;
Klein, N;
Bastiaans, D;
Burger, D;
... Welch, S; + view all
(2018)
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: Optimizing health in preparation for adult life.
HIV Medicine
, 19
(1)
e1-e42.
10.1111/hiv.12217.
|
Barlow‐Mosha, Linda Namutebi;
Ahimbisibwe, Grace Miriam;
Chappell, Elizabeth;
Amuge, Pauline Mary;
Nanduudu, Annet;
Kaudha, Elizabeth;
Amukele, Timothy;
... Turkova, Anna; + view all
(2023)
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub‐study of the ODYSSEY randomized controlled trial.
Journal of the International AIDS Society
, 26
(9)
, Article e26174. 10.1002/jia2.26174.
|
Bohlius, J;
Foster, C;
Naidu, G;
Sengayi, M;
Turkova, A;
(2018)
Cancer in adolescents and young adults living with HIV.
Current Opinion in HIV and AIDS
, 13
(3)
pp. 196-203.
10.1097/COH.0000000000000460.
|
Bollen, PDJ;
Moore, CL;
Mujuru, HA;
Makumbi, S;
Kekitiinwa, AR;
Kaudha, E;
Parker, A;
... ODYSSEY trial team, .; + view all
(2020)
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial.
The Lancet HIV
, 7
(8)
e533-e544.
10.1016/S2352-3018(20)30189-2.
|
Botha, Johannes C;
Byott, Matthew;
Spyer, Moira J;
Grant, Paul R;
Gärtner, Kathleen;
Chen, Wilson X;
Burton, James;
... Nastouli, Eleni; + view all
(2023)
Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.
Viruses
, 15
(9)
, Article 1811. 10.3390/v15091811.
|
Butler, K;
Inshaw, J;
Ford, D;
Bernays, S;
Scott, K;
Kenny, J;
Klein, N;
... Gibb, D; + view all
(2016)
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Health Technology Assessment
, 20
(49)
10.3310/hta20490.
|
Chabala, Chishala;
Turkova, Anna;
Kapasa, Monica;
LeBeau, Kristen;
Tembo, Chimuka H;
Zimba, Kevin;
Weisner, Lubbe;
... SHINE trial team; + view all
(2023)
Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
The Pediatric Infectious Disease Journal (PIDJ)
10.1097/INF.0000000000004047.
(In press).
|
Chabala, C;
Turkova, A;
Thomason, MJ;
Wobudeya, E;
Hissar, S;
Mave, V;
van der Zalm, M;
... Gibb, DM; + view all
(2018)
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): A study protocol for a randomised controlled trial.
Trials
, 19
(1)
, Article 237. 10.1186/s13063-018-2608-5.
|
Chandasana, Hardik;
Thapar, Mita;
Hayes, Siobhan;
Baker, Mark;
Gibb, Diana M;
Turkova, Anna;
Ford, Deborah;
... IMPAACT P1093, ODYSSEY (PENTA 20) Study Teams; + view all
(2023)
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Clinical Pharmacokinetics
10.1007/s40262-023-01289-5.
(In press).
|
Collins, J;
Turkova, A;
(2018)
Outcomes in children on raltegravir: a story of two halves.
[Editorial comment].
The Lancet HIV
, 5
(12)
e676-e678.
10.1016/S2352-3018(18)30332-1.
|
Cressey, TR;
Turkova, A;
(2024)
Expanding options of child-friendly, single-tablet regimens for young children with HIV.
The Lancet HIV
, 11
(5)
e275-e276.
10.1016/S2352-3018(24)00007-9.
|
Crook, AM;
Turkova, A;
Musiime, V;
Bwakura-Dangarembizi, M;
Bakeera-Kitaka, S;
Nahirya-Ntege, P;
Thomason, M;
... ARROW Trial Team; + view all
(2016)
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
BMC Medicine
, 14
(50)
pp. 1-11.
10.1186/s12916-016-0593-7.
|
Davies, M-A;
Gibb, D;
Turkova, A;
(2016)
Survival of HIV-1 vertically infected children.
Current Opinion in HIV and AIDS
, 11
(5)
pp. 455-464.
10.1097/COH.0000000000000303.
|
du Cros, P;
Greig, J;
Alffenaar, JWC;
Cross, GB;
Cousins, C;
Berry, C;
Khan, U;
... Marais, BJ; + view all
(2023)
Standards for clinical trials for treating TB.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
, 27
(12)
pp. 885-898.
10.5588/ijtld.23.0341.
|
Edgar, Kate;
The Epidemiology of Pregnancy and Paediatric, Infections International Cohort Collaboration (EPPICC) study gr;
(2025)
Changes in body mass index in children and adolescents living with HIV in Europe and Thailand starting dolutegravir.
Open Forum Infectious Diseases
, Article ofaf640. 10.1093/ofid/ofaf640.
(In press).
|
Eni-Olutu, Ayolola;
Mackie, Nicola E;
Glenn, Jessica;
Bailey, Angela;
Bamford, Alasdair;
Kenny, Julia;
Levin, Leon;
... Foster, Caroline; + view all
(2025)
Emerging integrase resistance in an international perinatal virtual clinic.
AIDS
, 39
(3)
pp. 276-280.
10.1097/QAD.0000000000004048.
|
Ford, D;
Turner, R;
Turkova, A;
Penazzato, M;
Musiime, V;
Bwakura-Dangarembizi, M;
Violari, A;
... Gibb, DM; + view all
(2018)
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV.
Journal of Acquired Immune Deficiency Syndromes
, 78
(Sup)
S40-S48.
10.1097/QAI.0000000000001748.
|
Foster, C;
Bamford, A;
Turkova, A;
Welch, S;
Klein, N;
PENTA Guidelines Writing Group and PENTA steering committee, .;
(2016)
Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV.
HIV Medicine
, 18
(2)
pp. 133-134.
10.1111/hiv.12399.
|
Fritschi, Nora;
Gureva, Tatyana;
Eliseev, Platon;
Jackson, Charlotte;
Milanzi, Edith;
Crichton, Siobhan;
Collins, Intira Jeannie;
... Ritz, Nicole; + view all
(2024)
Diagnosis of tuberculosis infection in children
with a novel skin test and the traditional
tuberculin skin test: An observational study.
PLoS ONE
, 19
(8)
, Article e0293272. 10.1371/journal.pone.0293272.
|
Galileya, Lufina Tsirizani;
Wasmann, Roeland E;
Chabala, Chishala;
Rabie, Helena;
Lee, Janice;
Njahira Mukui, Irene;
Hesseling, Anneke;
... Denti, Paolo; + view all
(2023)
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
PLoS Medicine
, 20
(11)
, Article e1004303. 10.1371/journal.pmed.1004303.
|
Gureva, T;
Turkova, A;
Yablokova, E;
Smirnova, P;
Sveshnikova, O;
Zolotaya, O;
Nikishova, E;
... Mariandyshev, A; + view all
(2022)
Fluoroquinolone preventive therapy for children exposed to MDR-TB.
The International Journal of Tuberculosis and Lung Disease
, 26
(2)
pp. 171-173.
10.5588/ijtld.21.0443.
|
Harausz, EP;
Garcia-Prats, AJ;
Law, S;
Schaaf, HS;
Kredo, T;
Seddon, JA;
Menzies, D;
... Hesseling, AC; + view all
(2018)
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
PLoS Medicine
, 15
(7)
, Article e1002591. 10.1371/journal.pmed.1002591.
|
Indolfi, G;
Bailey, H;
Serranti, D;
Giaquinto, C;
Thorne, C;
PENTAHep Study Group;
(2019)
Treatment and Monitoring of Children with Chronic Hepatitis C in the Pre-DAA Era: a European Survey of 38 Paediatric Specialists.
Journal of Viral Hepatitis
, 26
(8)
pp. 961-968.
10.1111/jvh.13111.
|
Jacobs, TG;
Svensson, EM;
Musiime, V;
Rojo, P;
Dooley, KE;
McIlleron, H;
Aarnoutse, RE;
... WHO Paediatric Antiretroviral Working Group; + view all
(2020)
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review.
Journal of Antimicrobial Chemotherapy
, 75
(12)
pp. 3433-3457.
10.1093/jac/dkaa328.
|
Judd, A;
Goodall, RL;
EPPICC Study Group, .;
(2018)
Long term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV in 17 middle- and high-income countries in Europe and Thailand: cohort study.
PLoS Medicine
, 15
(1)
, Article e1002491. 10.1371/journal.pmed.1002491.
|
Lanyon, C;
Seeley, J;
Namukwaya, S;
Musiime, V;
Paparini, S;
Nakyambadde, H;
Matama, C;
... Bernays, S; + view all
(2020)
"Because we all have to grow up": supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently.
Journal of the International AIDS Society (JIAS)
, 23
(S5)
, Article e25552. 10.1002/jia2.25552.
|
Malik, Farihah;
Crichton, Siobhan;
Plotnikova, Yulia;
Latysheva, Inga;
Samarina, Anna;
Pokorska-Śpiewak, Maria;
Gomez, Marisa Navarro;
... Collins, Intira Jeannie; + view all
(2024)
Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
The Pediatric Infectious Disease Journal
10.1097/INF.0000000000004271.
|
Martín-Bejarano García, M;
Jackson, C;
Okhonskaia, L;
Voronin, E;
Rozenberg, V;
Titova, MA;
Kovalenko, T;
... Martinez de Aragón, A; + view all
(2025)
Brain MRI and neurocognitive characteristics of children and adolescents living with HIV.
Child Neuropsychology
10.1080/09297049.2025.2517150.
(In press).
|
Matthews, Philippa C;
Ocama, Ponsiano;
Wang, Su;
El-Sayed, Manal;
Turkova, Anna;
Ford, Deborah;
Torimiro, Judith;
... Hamid, Saeed; + view all
(2023)
Enhancing interventions for prevention-of-mother-to-child- transmission (PMTCT) of hepatitis B virus (HBV).
JHEP Reports
, Article 100777. 10.1016/j.jhepr.2023.100777.
(In press).
|
|
Mave, V;
Paradkar, M;
Conradie, F;
Gupta, A;
Avihingsanon, A;
Meintjes, G;
Turkova, A;
... Chaisson, RE; + view all
(2025)
Tuberculosis disease among people with HIV: therapeutic advances.
The Lancet HIV
, 12
(5)
e367-e381.
10.1016/S2352-3018(25)00040-2.
|
McArdle, AJ;
Turkova, A;
Cunnington, AJ;
(2018)
When do co-infections matter?
Current Opinion in Infectious Diseases
, 31
(3)
pp. 209-215.
10.1097/QCO.0000000000000447.
|
Melvin, AJ;
Warshaw, M;
Compagnucci, A;
Saidi, Y;
Harrison, L;
Turkova, A;
Tudor-Williams, G;
(2017)
Hepatic, renal, hematologic, and inflammatory markers in HIV-infected children on long-term suppressive antiretroviral therapy.
Journal of the Pediatric Infectious Diseases Society
, 6
(3)
e109-e115.
10.1093/jpids/pix050.
|
Moore, C;
Turkova, A;
Mujuru, H;
Kekitiinwa, A;
Lugemwa, A;
Kityo, C;
Barlow-Mosha, L;
... ODYSSEY Trial Team; + view all
(2021)
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
BMC Infectious Diseases
, 21
, Article 5. 10.1186/s12879-020-05672-6.
|
Penazzato, M;
Townsend, CL;
Rakhmanina, N;
Cheng, Y;
Archary, M;
Cressey, TR;
Kim, MH;
... Townsend, C; + view all
(2019)
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list.
The Lancet HIV
, 6
(9)
E623-E631.
10.1016/S2352-3018(19)30193-6.
|
Post, FA;
Szubert, AJ;
Prendergast, AJ;
Johnston, V;
Lyall, H;
Fitzgerald, F;
Musiime, V;
... Pett, SL; + view all
(2018)
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clinical Infectious Diseases
, 66
(S2)
S132-S139.
10.1093/cid/cix1141.
|
Rojo, P;
Carpenter, D;
Venter, F;
Turkova, A;
Penazzato, M;
(2020)
The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV.
Journal of the International AIDS Society
, 23
(S5)
, Article e25576. 10.1002/jia2.25576.
|
Scott, Karen;
O'Rourke, John;
Jackson, Charlotte;
Ene, Luminita;
Galli, Luisa;
Goetghebuer, Tessa;
Henegar, Cassidy;
... Collins, Intira Jeannie; + view all
(2025)
Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With Human Immunodeficiency Virus (HIV) on Dolutegravir in Europe and Thailand.
Clinical Infectious Diseases
, 81
(4)
e115-e127.
10.1093/cid/ciaf191.
|
Seager, Ezgi;
Gillespie, Carrie;
Welch, Steven;
Cohen, Jonathan;
Turkova, Anna;
Antolin, Laura F;
(2025)
Shortened Treatment Regimens in Paediatric Tuberculosis: Results from The First UK Survey of Clinical Practice.
Journal of Pediatric Infectious Diseases
, 20
(5)
pp. 341-343.
10.53391/1305-7707.1038.
|
Seddon, JA;
Garcia-Prats, AJ;
Purchase, SE;
Osman, M;
Demers, A-M;
Hoddinott, G;
Crook, AM;
... Hesseling, AC; + view all
(2019)
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).
Trials
(In press).
|
Siika, A;
McCabe, L;
Bwakura-Dangarembizi, M;
Kityo, C;
Mallewa, J;
Berkley, J;
Maitland, K;
... Gibb, DM; + view all
(2018)
Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial.
Clinical Infectious Diseases
, 66
(S2)
S140-S146.
10.1093/cid/cix1142.
|
Smirnova, PA;
Turkova, A;
Nikishova, EI;
Seddon, JA;
Chappell, E;
Zolotaya, OA;
Mironuk, OM;
(2016)
Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study.
European Respiratory Journal
, 48
(5)
pp. 1496-1499.
10.1183/13993003.00354-2016.
|
Tierrablanca, LE;
Ochalek, J;
Ford, D;
Babiker, A;
Gibb, D;
Butler, K;
Turkova, A;
... BREATHER (PENTA 16) Trial Group; + view all
(2018)
Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries.
Medicine
, 97
(5)
, Article e9698. 10.1097/MD.0000000000009698.
|
Turkova, A;
White, E;
Mujuru, HA;
Kekitiinwa, AR;
Kityo, CM;
Violari, A;
Lugemwa, A;
... ODYSSEY Trial Team; + view all
(2021)
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
The New England Journal of Medicine
, 385
(27)
pp. 2531-2543.
10.1056/NEJMoa2108793.
|
Turkova, Anna;
Chan, Man K;
Kityo, Cissy;
Kekitiinwa, Adeodata R;
Musoke, Philippa;
Violari, Avy;
Variava, Ebrahim;
... D3 trial team; + view all
(2024)
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.
Contemporary Clinical Trials
, Article 107540. 10.1016/j.cct.2024.107540.
(In press).
|
Turkova, Anna;
Palmer, Megan;
Gibb, Diana M;
(2022)
Shorter Treatment for Tuberculosis in Children. Reply.
New England Journal of Medicine
, 386
(25)
pp. 2439-2440.
10.1056/NEJMc2204561.
|
Turkova, A;
Chappell, E;
Chalermpantmetagul, S;
Della Negra, M;
Volokha, A;
Primak, N;
Solokha, S;
... Thorne, C; + view all
(2016)
Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
The International Journal of Tuberculosis and Lung Disease
, 20
(11)
pp. 1448-1456.
10.5588/ijtld.16.0067.
|
Turkova, A;
Chappell, E;
Judd, A;
Goodall, RL;
Welch, SB;
Foster, C;
Riordan, A;
... Collaborative HIV Paediatric Study (CHIPS) Steering Committee; + view all
(2015)
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.
The Lancet HIV
, 2
(12)
e530-e539.
10.1016/S2352-3018(15)00200-3.
|
Turkova, A;
Kampmann, B;
(2017)
Short course treatment for MDR TB: jumping the gun?
Thorax
, 72
(9)
p. 773.
10.1136/thoraxjnl-2017-210163.
|
Turkova, A;
Moore, CL;
Butler, K;
Compagnucci, A;
Saïdi, Y;
Musiime, V;
Nanduudu, A;
... BREATHER (PENTA 16) Trial Group, .; + view all
(2018)
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
, 13
(4)
, Article e0196239. 10.1371/journal.pone.0196239.
|
Turkova, A;
Tebruegge, M;
Brinkmann, F;
Tsolia, M;
Mouchet, F;
Kampmann, B;
Seddon, JA;
(2017)
Management of child MDR-TB contacts across countries in the WHO European Region: A survey of current practice.
International Journal of Tuberculosis and Lung Disease
, 21
(7)
pp. 774-777.
10.5588/ijtld.16.0949.
|
Turkova, A;
Volynets, GV;
Crichton, S;
Skvortsova, TA;
Panfilova, VN;
Rogozina, NV;
Khavkin, AI;
... Thorne, C; + view all
(2019)
Advanced liver disease in Russian children and adolescents with chronic hepatitis C.
Journal of Viral Hepatitis
, 26
(7)
pp. 881-892.
10.1111/jvh.13093.
|
Waalewijn, H;
Almett, M;
Wasmann, RE;
Cressey, TR;
Easterbrook, P;
Olumese, PE;
Hesseling, AC;
... van der Laan, LE; + view all
(2025)
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas.
The Lancet Child & Adolescent Health
, 9
(4)
pp. 274-282.
10.1016/S2352-4642(25)00025-2.
|
Waalewijn, H;
Turkova, A;
Rakhmanina, N;
Cressey, TR;
Penazzato, M;
Colbers, A;
Burger, DM;
(2019)
Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV.
Therapeutic Drug Monitorin
, 41
(4)
pp. 431-443.
10.1097/FTD.0000000000000637.
|
Wademan, DT;
Busakwe, L;
Nicholson, TJ;
van der Zalm, M;
Palmer, M;
Workman, J;
Turkova, A;
... Hoddinott, G; + view all
(2019)
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.
International Journal of Tuberculosis and Lung Disease
, 23
(12)
pp. 2363-2368.
10.5588/ijtld.19.0115.
|
Digital scholarly resource
Bamford, Alasdair;
Bernardi, Stefania;
Bologna, Rosa;
Burger, David;
Butler, Karina;
Castelli, Guido;
Cressey, Tim;
... Welch, Steven; + view all
(2019)
Penta HIV guidelines writing group on behalf of Penta. Penta HIV first and second line antiretroviral treatment guidelines 2019.
[Digital scholarly resource].
https://penta-id.org/hiv/treatment-guidelines/
|